KAYLA WILLIAMSON: Open Payments
NPI 1982076923 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,097 in 149 payments from 24 companies in 2025. Trend: 2023 $1,932 · 2024 $1,818 · 2025 $3,097
Food & beverage: $2,997Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 31 | $509 |
| AstraZeneca Pharmaceuticals LP | 12 | $373 |
| Verona Pharma, Inc. | 15 | $318 |
| Regeneron Healthcare Solutions, Inc. | 10 | $208 |
| Insmed, Inc. | 10 | $198 |
| GENZYME CORPORATION | 7 | $171 |
| Amgen Inc. | 13 | $143 |
| HARMONY BIOSCIENCES LLC | 2 | $133 |
| Genentech USA, Inc. | 6 | $119 |
| Axsome Therapeutics, Inc. | 5 | $119 |
Products named: DUPIXENT, TRELEGY ELLIPTA, Ohtuvayre, AIRSUPRA, Arikayce, TEZSPIRE, NUCALA, Xolair.
Industry payments across TX — which companies pay providers there.
